4 advances in AI and nephrology in 2023
In a recent review (Shickel, 2024) 4 advances in how A1 may advance nephrology were described.
- The launch of ChatGPT1 was an important step in the democratisation of artificial intelligence (AI); similar systems will have a critical role in shaping future research and AI-augmented clinical practice in nephrology
- An automated quantitative histopathological morphometry approach, termed ‘pathomics’, reliably predicted the progression of CKD8; this technology may represents an important step towards slowing the progression of CKD
- An AI system reliably estimated biomarkers of systemic diseases, including estimated glomerular filtration rate (eGFR), from external retinal photographs9; this approach offers new opportunities for noninvasive, inexpensive and scalable screening for kidney disease in low-resource settings
- An AI analysis of blood-flow sounds detected arteriovenous fistula stenoses in patients on haemodialysis; with comparable performance to an expert nephrologist performing a physical examination10; this approach has the potential for computerised medical assessments.
Last Reviewed on 26 June 2024